ACR Convergence 2026 Archives - ACR Meeting Abstracts

Abstract Number: 2569

Pain and Functional Outcomes Following Low-Dose Radiation Therapy (LDRT) for Hand Osteoarthritis
Abstract Number: 1555

Pain Catastrophizing Predicts Fibromyalgia Treatment Outcome Independent of Treatment Modality Selection
Abstract Number: 2570

Pain Features Associated with Unpredictable Pain Among Knees with Intermittent Pain in the Multicenter Osteoarthritis Study
Abstract Number: 2597

Pain Phenotypes in Patients with Inflammatory Myopathies: A Latent Class Analysis
Abstract Number: 2571

Pain-flares in a knee OA clinical trial: Incidence, duration, and risk factors
Abstract Number: 2439

Pain-Inflammation Discordance Identifies Patients at High Risk for Adverse Clinical Outcomes in Rheumatoid Arthritis: A Retrospective Cohort Study From the NinJa Registry
Abstract Number: 2911

Paired Muscle and Blood Transcriptomics Reveal Distinct Tissue and Systemic Transcriptional Signatures Across Myositis Subtypes
Abstract Number: 1538

Palliative Care Attitudes and Acceptability in Systemic Lupus Erythematosus and Systemic Sclerosis: A Cross-Sectional Patient Survey
Abstract Number: 0690

Pancreatic and Extrapancreatic IgG4-Related Disease Relapses are Common Following Treatment Initiation Across All Autoimmune Pancreatitis Phenotypes
Abstract Number: 1757

Paradoxical Cardioprotection in RA and PsA: Demonstration of Berkson’s Bias Via National Inpatient Sample, 2016-23
Abstract Number: 0274

Paradoxical Trends in SLE: Rising Glucocorticoid Initiation and Burden Despite Expanded Glucocorticoid-Sparing Therapy in a Population-Based Cohort
Abstract Number: 1696

Parotid Ultrasound Elastography in Sjögren’s Disease: Feasibility and Association with Disease Activity
Abstract Number: 2076

Passenger Variants in Interleukin-1 and TP53 Pathways Co-Occurring with Clonal Hematopoiesis Drivers Associate with Increased Risk of Giant Cell Arteritis and Polymyalgia Rheumatica
Abstract Number: 0326

Pathogenic Glucose-6-Phosphate Dehydrogenase (G6PD) Variants Correlate with Increased Lupus Nephritis Prevalence in Systemic Lupus Erythematosus (SLE)
Abstract Number: 0062

Pathogenic strains of a gut commensal drive an endotype of lupus nephritis identified by a distinct serum proteomics profile of thromboinflammation with features of sepsis
Abstract Number: 0582

Patient & Caregiver Global Score is a Predictor of Risk of JIA Flare: A Retrospective Cohort Study in the CARRA Registry
Abstract Number: 2505

Patient and Parent Qualitative Feedback on a Resilience Coaching Program for Adolescents with Chronic Musculoskeletal Pain
Abstract Number: 2969

Patient awareness of clinical trials remains a barrier to enrollment; a single site survey at an academic center
Abstract Number: 2263

Patient Experiences with Home Urine Protein Testing in Patients at High Risk of Lupus Nephritis: A Qualitative Study
Abstract Number: 2372

Patient Global Assessment Correlates With the EULAR Sjögren’s Syndrome Patient Reported Index (ESSPRI) and the Sjögren’s Syndrome Symptom Diary (SSSD) in the Pooled Phase 3 NEPTUNUS Studies
Abstract Number: 1805

Patient Interests and Perspectives on Pillars of Lifestyle Medicine in Rheumatology
Abstract Number: 1539

Patient Perspectives on Allogeneic CAR T Cell Therapy in Systemic Lupus Erythematosus: Findings from a Focus Group Study (Part 3)
Abstract Number: 2178

Patient Perspectives on Skin Care in Scleroderma: Concerns, Utilization and Barriers to Access
Abstract Number: 2531

Patient Preferences for Uricase Treatments in Uncontrolled Gout in the United States: A Discrete Choice Experiment
Abstract Number: 0601

Patient reported priorities persist despite low disease activity in Axial Spondyloarthritis: insights beyond composite disease activity measures
Abstract Number: 0602

Patient satisfaction: Preliminary results from the FASTRAX interprofessional model of care with extended scope practitioners
Abstract Number: 0612

Patient Understanding of Rheumatology Medications After Pharmacist-Led Education
Abstract Number: 2759

Patient- and Community-Level Characteristics Associated with Patient Global in Patients with Inflammatory Rheumatic and Musculoskeletal Disease
Abstract Number: 0990

Patient-derived human lung organoids recapitulate epithelial-mesenchymal remodeling and antifibrotic responses in SSc-ILD
Abstract Number: 2023

Patient-derived synovial organoids as an inflammatory driver of cartilage degeneration in in-vitro engineered human joint disease models
Abstract Number: 1853

Patient-Derived Synovium-on-a-Chip Modeling of Stromal-Immune Interactions in Psoriatic Arthritis
Abstract Number: 1789

Patient-Level Persistence of On-Treatment Remission with Guselkumab: Pooled Results from VOYAGE 1 and VOYAGE 2 Participants with Moderate-to-Severe Plaque Psoriasis
Abstract Number: 2264

Patient-Perceived Choice in Treatment Decisions Is Associated with Lower Q-SLAQ Disease Burden and Improved QoL in SLE
Abstract Number: 0617

Patient-Physician Discordance and Affected Joint Distribution Associated with Unacceptable Pain in Rheumatoid Arthritis: Analysis Based on a Large National Database in Japan
Abstract Number: 0603

Patient-Physician Discordance in Psoriatic Arthritis Is Associated with Worse Physical Health Status
Abstract Number: 0850

Patient-Reported Barriers to Follow-Up Care Are Associated with Higher Damage Scores in Idiopathic Inflammatory Myopathies: a Hispanic cohort.
Abstract Number: 0327

Patient-Reported Cognitive Difficulties in Systemic Lupus Erythematosus: Insights from Individuals with and without Cognitive Impairment
Abstract Number: 1599

Patient-Reported Dyspnea and Cough in Myositis With and Without Interstitial Lung Disease
Abstract Number: 2873

Patient-Reported Health Status Is Associated with Mortality in Systemic Sclerosis Across Key Disease Characteristics: Data from the Norwegian NOSVAR Registry
Abstract Number: 1519

Patient-Reported Outcome Differences by Treatment Pathway in a Pediatric Cohort With Juvenile Idiopathic Arthritis and Uveitis
Abstract Number: 2218

Patient-Reported Outcomes After 12 Months of Real-World Anifrolumab Treatment: Interim Results From a Multinational, Real-World Study
Abstract Number: 2301

Patient-Reported Outcomes in Participants With Active and Erosive Psoriatic Arthritis Receiving Guselkumab: Results Through Week 48 of a Phase 3b, Randomized Double-Blind, Placebo-Controlled Study
Abstract Number: 1540

Patient-Reported Symptom Priorities and Treatment Goals Across Five Inflammatory Conditions
Abstract Number: 0394

Patient-Reported Treatment Success and Clinical DAPSA Define Prognostic Disease States in Psoriatic Arthritis
Abstract Number: 2696

Patients with rheumatoid arthritis exhibit greater coronary plaque redistribution toward higher-risk segments that increases with age independently of burden compared with matched controls
Abstract Number: 2179

Patients with VEDOSS already show the molecular signs of systemic sclerosis, even though their organs are not involved
Abstract Number: 1816

Patterns and Clinical Relevance of Antiphospholipid Antibody Profiles in Children
Abstract Number: 1727

Patterns and Predictors of Antiphospholipid Antibody Screening in an Incident Systemic Lupus Erythematosus Cohort
Abstract Number: 2506

Patterns of Primary Care Engagement in Childhood Systemic Lupus Erythematosus
Abstract Number: 1389

Patterns of Systemic Organ Involvement and Symptom Burden Across Defined Subgroups of Patients With Sjögren’s Disease: A Real-World Analysis
Abstract Number: 2835

PCDH18, a Novel Susceptibility Gene for MDA5-Positive Dermatomyositis-Associated RP-ILD, Drives Fibroblast Activation and Fibroinflammatory Lung Injury
Abstract Number: 0940

PD-1 Blockade Unleashes Pathogenic TH17 Differentiation That Mediates Inflammatory Arthritis
Abstract Number: 0011

PD-1+CD8+ T cells are hyperactivated and associated with refractory systemic lupus erythematosus
Abstract Number: 1955

PD-1H Immune Checkpoint Activation Reinforces Human T-Cell Tolerance and Attenuates Lupus-Associated Renal Pathology
Abstract Number: 0107

PD1-Expressing Regulatory T Cells Suppress T Cell-B Cell Interactions in Inflamed Peripheral Tissues
Abstract Number: 0662

Peak FiO₂ Within the First Week Identifies Patients Requiring Rescue Therapy in Anti-MDA5 Dermatomyositis-Associated Interstitial Lung Disease
Abstract Number: 2919

Peak Prednisone dose above 20 mg per day to treat rheumatologic side effects of immune checkpoint inhibitors is associated with shorter overall survival
Abstract Number: 2480

PedsRheumSim: High-Fidelity Simulation for Pediatric Rheumatology Learners
Abstract Number: 2265

Per- and Polyfluoroalkyl ‘Forever Chemicals’ and Systemic Lupus Outcomes
Abstract Number: 0063

Per- and Polyfluouralkyl Substances (PFAS) Correlate with and Improve the Ability of Select Immune Biomarkers to Differentiate Stage 2 (Pre-classification) SLE vs. Unaffected Lupus Relatives in a Nested Study of the Lupus Autoimmunity in Relatives (LAUREL) Follow-up Cohort
Abstract Number: 1541

Perceptions, Attitudes, and Practices Regarding Routine Vaccinations Among Patients with Vasculitis
Abstract Number: 1919

Performance of a Large Language Model for Chart Abstraction in Rheumatologic Autoimmune Disease Research
Abstract Number: 0395

Performance of Sacroiliac Joint and Spinal MRI Lesions in Early Axial Spondyloarthritis: Data from the SPondyloArthritis Caught Early (SPACE) Cohort
Abstract Number: 0891

Performance of Structural Lesion MRI cut-offs for an MRI Indicative of Axial Spondyloarthritis in the Spondyloarthritis Research and Treatment Network Classification of Axial Spondyloarthritis Inception Cohort Study
Abstract Number: 2878

Performance of the ASAS-SPARTAN 2025 Revised Classification Criteria for Axial Spondyloarthritis in a Multicenter Inception Cohort with Psoriasis, Uveitis, or Colitis Presenting with Undiagnosed Back Pain
Abstract Number: 0396

Performance of the DUET ultrasound enthesitis score in a real-world setting as a diagnostic tool in early PsA: An external validation prospective cohort study (PREDICT Study)
Abstract Number: 2861

Performance of the PREVENT Risk Assessment Calculator for Predicting Heart Failure in Patients with Systemic Lupus Erythematosus
Abstract Number: 0499

Periodontitis is Independently Associated with Higher C-Reactive Protein Levels in Rheumatoid Arthritis Patients
Abstract Number: 2801

Perioperative Complement Inhibition with Eculizumab in High-Risk Antiphospholipid Syndrome: A Case Series
Abstract Number: 1453

Peripheral Blood Absolute Eosinophil Counts are Elevated in Rheumatoid Arthritis-Associated Interstitial Lung Disease
Abstract Number: 0036

Peripheral Blood Single-Cell RNA Sequencing Reveals Distinct Gene Signatures in Systemic Sclerosis Patients With and Without Interstitial Lung Disease
Abstract Number: 0073

Peripheral blood transcriptomic programs distinguish radiographic progression trajectories in axial spondyloarthritis independent of disease activity and treatment
Abstract Number: 2058

Peripheral Blood Transcriptomics Reveals a Distinct Immune Network Architecture in Anti-MDA5 Dermatomyositis
Abstract Number: 0012

Peripheral T Cell Immunophenotyping Identifies Terminally Differentiated Cytotoxic CD8 T Cell Expansion, Effector Memory T Cell Depletion, and anti-Ro-Associated CD38⁺ CD4 T Cell Activation in Sjögren’s Disease
Abstract Number: 1058

Peripheral Treg and CD28-Negative T-Cell Profiles in Rheumatoid Arthritis Reflect Inflammatory and Clinical Burden More Than Age at Onset
Abstract Number: 0461

Persistence and and optimization of baricitinib in rheumatoid arthritis in real-world practice: survival analysis, causes of discontinuation, and predictive factors
Abstract Number: 2668

Persistence and Predictors of Outcome in Epidemic Post-Viral Arthritis: A Prospective Cohort Study From Western India
Abstract Number: 0368

Persistence, Effectiveness, Safety, and Patient Reported Impact of Guselkumab and IL-17 Inhibitors in Psoriatic Arthritis: Full Population Results of the PsABIOnd Global Observational Study Over 12 Months
Abstract Number: 1353

Persistent Disease Burden among patients with Psoriatic Arthritis Despite Apparent Clinical Improvement: A Real-World Global Survey
Abstract Number: 2760

Persistent Excess Respiratory Infection Burden Despite High Vaccination Uptake in Systemic Lupus Erythematosus: A Population-Based Matched Cohort Study
Abstract Number: 2440

Persistent Frailty Despite Sustained Remission in Rheumatoid Arthritis: A Six-Year Longitudinal Study
Abstract Number: 0820

Persistent Sex Disparity in Rheumatoid Arthritis-Related Mortality with a Musculoskeletal Underlying Cause in the United States, 2018-2024: A National Multiple Cause of Death Analysis
Abstract Number: 2180

Persistent Systemic Inflammation Defines a Distinct High-Risk Phenotype in Systemic Sclerosis: Insights from the EUSTAR PERSISTS Study (PERsistent Systemic Inflammation in SysTemic Sclerosis)
Abstract Number: 1710

Persisting Racial and Ethnic Disparities in Systemic Lupus Erythematosus Hospitalizations in the United States
Abstract Number: 0114

PEX5 acts as a negative regulator of RANKL-induced osteoclastogenesis in vitro and inflammatory calvarial bone destruction in vivo
Abstract Number: 0369

Pharmacodynamic Biomarkers in Biologic-Naïve Participants With Active and Erosive Psoriatic Arthritis: Results Through Week 48 From the Phase 3 APEX Study
Abstract Number: 0275

Pharmacodynamics of Nipocalimab, a Fully Human FcRn-Blocking Monoclonal Antibody, in Adults With Systemic Lupus Erythematosus: Results From a Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study (JASMINE-SLE)
Abstract Number: 1824

Pharmacogenomic Associations of Methotrexate Metabolite Concentrations in a Cohort of Juvenile Idiopathic Arthritis
Abstract Number: 2340

Pharmacological treatments for psoriatic arthritis: A systematic review and network meta-analysis of randomized trials
Abstract Number: 1417

Phase 1 Study of Plamotamab, a Bispecific CD20xCD3 T-cell Engager, In Adult Patients With Rheumatoid Arthritis: Interim Results
Abstract Number: 2302

Phenotype-Based Treatment Response Patterns in Non-Radiographic Axial Spondyloarthritis Across Randomized Trials
Abstract Number: 2117

Phenotypic and Therapeutic Differences Between Pediatric and Adult-Onset Takayasu Arteritis: A Comparative Cohort Study from a National Referral Center
Abstract Number: 2118

Phenotypic differences across Giant cell arteritis-Polymyalgia rheumatica Spectrum Disease (GPSD): A multicentre prospective Irish cohort
Abstract Number: 1142

Phenotypic Differences in Behçet Disease According to Age at Diagnosis
Abstract Number: 0691

Phenotypic, Therapeutic, and Genetic Heterogeneity of the Patients Misclassified as MEFV-Negative Familial Mediterranean Fever: A Multistep Analysis
Abstract Number: 1073

Phosphoproteomic and biodistribution analyses demonstrate sustained target engagement by CR10049 in a rat model of inflammatory OA phenotype
Abstract Number: 1520

Physical Activity Guidance in Juvenile Myositis: A Cross-Sectional Survey of Providers and Families
Abstract Number: 0851

Physician Perspectives on Osteoporosis Screening in Men: Variability in Practice Patterns and Guideline Awareness
Abstract Number: 2373

Physician Practice Variability and Disease Monitoring Strategies in Sjögren Disease Across the MENA Region: A Regional Survey Analysis
Abstract Number: 1728

Physician Utilization Preferences for CAR T Cell Therapy in Myositis: Insights from a Quantitative Survey
Abstract Number: 1059

Physiologic Citrullination of IgG3 Generates Epitopes Recognized by Rheumatoid Arthritis Autoantibodies
Abstract Number: 1521

Pilot Randomized Controlled Trial of Resilience Coaching for Adolescents with Chronic Musculoskeletal Pain: Improved Patient Resilience and Reduced Parent Pain Catastrophizing
Abstract Number: 1194

Pilot Study Assessing Home Spirometry for Lung Function Trajectory Monitoring in Systemic Sclerosis-Associated Interstitial Lung Disease
Abstract Number: 0991

PINK1 activates SMAD3 upon mitochondrial dysfunction in Systemic Sclerosis (SSc) skin leading to a cascade of type 1 interferon signalling and further mitochondrial damage
Abstract Number: 0821

Place of Death in Systemic Sclerosis: A Two-Decade U.S. Shift from Hospital to Home
Abstract Number: 0151

Plasma cell profiling in SLE demonstrates a unique gene expression profile of IgA plasma cells.
Abstract Number: 1628

Plasma Cell-Targeted Therapy with Teclistamab in Treatment-Refractory Autoimmune Diseases
Abstract Number: 0717

Plasma metabolomics and female gout risk: a prospective study of ~900 circulating metabolites across >100 pathways in US women
Abstract Number: 1010

Plasma Proteomic Signatures of Nociplastic Pain in Systemic Lupus Erythematosus: A UK Biobank Cohort Study
Abstract Number: 2841

Plasma Proteomic Stratification Identifies Clinically Distinct Subgroups of Systemic Lupus Erythematosus
Abstract Number: 2052

Plasma Proteomics of NLPR3 Inhibition in Inflammatory Knee Osteoarthritis from a Phase II Clinical Trial
Abstract Number: 2852

Platelets activate remigrating neutrophils in systemic lupus erythematosus and represent a therapeutic target
Abstract Number: 1045

Platform for 3D peripheral nerve imaging of synovium in rheumatoid arthritis
Abstract Number: 0732

Pneumocystis Jirovecii Pneumonia in Autoimmune Diseases Receiving Steroids and Immunosuppressive Therapy: Mortality Outcomes and Prophylaxis Gaps
Abstract Number: 0897

Pneumocystis jirovecii Pneumonia in Giant Cell Arteritis by Steroid-Sparing Therapy Exposure: A 10-Year U.S. Cohort Study
Abstract Number: 0182

Polyarteritis nodosa: a multicenter study of etiologic profiles, clinical phenotypes and outcomes
Abstract Number: 0006

Polygenic Risk for Nasal Polyps in ANCA-Associated Vasculitis
Abstract Number: 2119

Polymyalgia rheumatica versus elderly-onset rheumatoid arthritis : a systematic review and meta-analysis on pathophysiology, diagnosis and clinical evolution
Abstract Number: 2789

Polypharmacy and medication non-adherence in adults with systemic lupus erythematosus
Abstract Number: 2790

Polypharmacy in systemic autoimmune rheumatic disease: a systematic review
Abstract Number: 0183

Pooled Prevalence of Gastrointestinal Involvement in VEXAS Syndrome: A Systematic Review and Meta-Analysis with Clinical Outcome Correlation
Abstract Number: 2651

Pooled Results From the Phase 3 Trials of Nanoencapsulated Sirolimus Plus Pegadricase in Uncontrolled Gout: Characterization of Adverse Events of Special Interest
Abstract Number: 1629

Pooled safety of cizutamig, a BCMA×CD3 T-cell engager, in patients with autoimmune diseases
Abstract Number: 0920

Poor Air Quality is Associated With Increased Risk Of Systemic Lupus Erythematosus Onset
Abstract Number: 0745

Poor quality of life in patients with immune checkpoint inhibitor-associated sicca symptoms
Abstract Number: 2266

Poor Renal Outcomes in Lupus Podocytopathy in a Predominantly African American Cohort
Abstract Number: 0500

Poorer Mental Health at Initiation of First Advanced Therapy in Early RA is Associated with Higher Medication Concerns and Earlier Treatment Discontinuation: Findings from the Canadian Early Arthritis Cohort (CATCH)
Abstract Number: 1454

Population Attributable Risk of Dementia in Rheumatoid Arthritis Over 10-years: Impact of Cardiovascular Disease, Serostatus, and Cumulative Inflammatory Burden
Abstract Number: 2219

Population Pharmacokinetics and Exposure-Response Analyses of Subcutaneous and Intravenous Anifrolumab in Patients With Systemic Lupus Erythematosus
Abstract Number: 0796

Post-Discharge Interventions in Hospitalized Rheumatology Patients: Impact of Early Phone Call Outreach and Outpatient Social Work Engagement on Clinic Follow-Up and Readmission Risk
Abstract Number: 1862

Post-Treatment Proteinuria Imperfectly Predicts Histological Remission in Lupus Nephritis: Repeat Biopsy Data from ReBioLup Support Reappraisal of Trial Endpoints
Abstract Number: 0761

Posterior Element Lesions in Axial Spondyloarthritis: 10-Year Follow-Up from the DESIR cohort
Abstract Number: 0152

Potent B-Cell Depletion with Zero Cytokine Release via a Novel αβTCR-Directed T-Cell Engager for Autoimmune Therapy
Abstract Number: 0663

Potential-Adjusted Total Improvement Score in Idiopathic Inflammatory Myopathies
Abstract Number: 2762

Pre-diagnostic Patterns of Routine Blood Test Values in Rheumatoid Arthritis: A Longitudinal Linked Data Study in the UK
Abstract Number: 0501

Pre-existing Rheumatoid Arthritis (RA) and Frailty as Independent Factors Associated with Mortality in Veterans with Genitourinary (GU) Cancers
Abstract Number: 1790

Pre-Index and Persistent Diagnosis Codes Among Adults Diagnosed With Systemic Lupus Erythematosus
Abstract Number: 2947

Pre-Referral Workup, Care Pathway Intervals, and Inflammatory Arthritis Diagnostic Yield Among 197,642 New VA Rheumatology Referrals, 2016-2024
Abstract Number: 1631

Pre-Test Probability of VEXAS Syndrome: A Stratified Meta-Analysis of UBA1 Screening Yield
Abstract Number: 0136

Precise genome editing at single-cell resolution reveals B cell state-dependent pathogenicity of the CD40 autoimmune locus
Abstract Number: 2761

Precision Phenotyping of Aortitis: A Cluster Based Study from a Referral Vasculitis Clinic
Abstract Number: 2709

Precision Rheumatology and the Sex Divide: A Systematic Review and Meta-Analysis of Sex-Based Differences in Disease Activity, Treatment Persistence and Quality of Life in Rheumatoid and Psoriatic Arthritis
Abstract Number: 2818

Precision Screening For Rapid Pain Progression In Knee Osteoarthritis Using Externally Validated Machine Learning
Abstract Number: 1111

Precision Targeting of Autoreactive B Cells with Next-Generation CATCR-T Cells
Abstract Number: 0153

Preclinical Characterization and Development of a Novel BCMA- and CD19- Dual Targeting T Cell Engager, LUB017, Capable of Deep Depletion of B Cells and Autoantibody for the Treatment of Autoimmune Diseases
Abstract Number: 0974

Preclinical Characterization of ATG-207, a Masked and TGFβRIII-Biased αCD3-TGF-β Bi-specific Fusion Protein, for the Treatment of T cell-related Autoimmune Diseases
Abstract Number: 2851

Preclinical Evaluation of a Lymphodepletion-free Approach for the Treatment of SLE Using an Armored Allogeneic CD19 Chimeric Antigen Receptor Expressing Epstein-Barr Virus Specific T cell Therapy
Abstract Number: 2727

Predicators of Physical Therapy Utilization Among U.S. Adults with Rheumatic Diseases: Online Cross-Sectional Study
Abstract Number: 2572

Predicting development of radiographic knee osteoarthritis using a machine learning ensemble: The Multicenter Osteoarthritis Study
Abstract Number: 1835

Predicting good long-term prognosis in anti-CCP antibody positive individuals with musculoskeletal symptoms: 10-year data from a national prospective research cohort.
Abstract Number: 2680

Predicting Immune-Related Inflammatory Arthritis in Patients with Cancer Receiving Immunotherapy Using Machine Learning
Abstract Number: 2636

Predicting Kidney Leukocyte Frequencies from Urine Leukocytes in Lupus Nephritis
Abstract Number: 2598

Predicting Pulmonary Outcomes in Anti-MDA5 Dermatomyositis: The Role of Easily Accessible Biomarkers
Abstract Number: 2441

Predicting Short-Term Hip and Major Osteoporotic Fracture Risk in Rheumatoid Arthritis: Development and Validation of Novel Risk Models
Abstract Number: 0397

Predicting Spinal Radiographic Progression From One-Year Routine Clinical Data of Patients with Ankylosing Spondylitis
Abstract Number: 2806

Predicting the outcome of immune checkpoint inhibitor-induced inflammatory arthritis and arthralgia: Development of multivariable models to predict disease persistence
Abstract Number: 0241

Prediction of future significant organ involvement in very early and mild systemic sclerosis: a European Scleroderma Trials and Research Group analysis
Abstract Number: 2579

Prediction of Postoperative Risk Following Primary Total Hip Arthroplasty Using Machine Learning Models
Abstract Number: 2181

Prediction of Systemic Sclerosis-Interstitial Lung Disease Progression Utilizing an AI-Based HRCT Scoring System
Abstract Number: 1162

Predictive Value of Baseline Kidney Function and Histopathology for Early Renal Outcomes in ANCA-Associated Vasculitis
Abstract Number: 1323

Predictors of ASAS40 Response to Ivarmacitinib in Patients with Active Ankylosing Spondylitis: A Post-hoc Analysis of a Randomized, Double-blind, Placebo-controlled Phase II/III Trial
Abstract Number: 1324

Predictors of b/tsDMARD Discontinuation and Treatment Response in Psoriatic Arthritis: Results from the British Society for Rheumatology Psoriatic Arthritis Register
Abstract Number: 0328

Predictors of Lupus Flares According to the Duration of Sustained Drug-Free Remission: Data from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
Abstract Number: 2544

Predictors of Neuropathic-like Pain in Inflammatory Arthritis: Results from the NEUPIA Study
Abstract Number: 0628

Predictors of Osteoporosis Undertreatment Among U.S. Adults With Physician-Diagnosed Osteoporosis: NHANES 2017-2020
Abstract Number: 0370

Predictors of PASI Response to Tildrakizumab: Insights from Elastic Net Modeling of Pooled Phase 3 Trials
Abstract Number: 2182

Predictors of Patient-Reported Dyspnea in Early Systemic Sclerosis: A Prospective Study of a Multicenter Cohort
Abstract Number: 0204

Predictors of Remission and Comparative Safety in ANCA Associated Vasculitis: Real World Analysis of Cyclophosphamide vs Rituximab
Abstract Number: 1278

Predictors of Remission and Lupus Low Disease Activity State in Systemic Lupus Erythematosus Patients. Data from the Almenara Lupus Cohort
Abstract Number: 1390

Predictors of Severe Infection and Exploratory Risk Stratification in Systemic Lupus Erythematosus and Primary Sjögren Syndrome
Abstract Number: 1195

Predictors of Short-Term Gastrointestinal Progression in Systemic Sclerosis: Data from the German Network for Systemic Sclerosis Cohort
Abstract Number: 1630

Predictors of Systemic Autoimmune Rheumatic Disease Evolution in Interstitial Pneumonia with Autoimmune Features: A Systematic Review and Meta-Analysis
Abstract Number: 1143

Predictors of Tocilizumab Failure in Giant Cell Arteritis
Abstract Number: 2637

Predominance of HLA-B35 and HLA-B40 Over HLA-B27 in a Colombian Cohort of Patients With Non-Infectious Uveitis
Abstract Number: 1848

Pregnancies in Patients with Autoimmune Disease Receiving CAR T-Cell Therapy
Abstract Number: 2462

Pregnancy and Infant Outcomes in Systemic Lupus Erythematosus and Lupus Nephritis: A National Electronic Health Record-Based Study
Abstract Number: 1279

Pregnancy and Obstetric Outcomes in Systemic Lupus Erythematosus: Insights from the GLADEL 2.0 Cohort
Abstract Number: 2860

Pregnancy as a Window to Future Systemic Autoimmune Rheumatic Diseases: Adverse Pregnancy Outcomes and Future Risk of SLE and RA in a Norwegian Population-Based Pregnancy Cohort
Abstract Number: 0537

Pregnancy Experiences and Reproductive Decision-Making in Women with Systemic Rheumatic Diseases
Abstract Number: 2463

Pregnancy Outcomes in Sarcoidosis: A Systematic Review and Meta-analysis
Abstract Number: 1474

Pregnancy Outcomes Prior to, at the Time of, and After the Diagnosis of Systemic Lupus Erythematosus in an Historic, Multicenter, Multi-ethnic/racial Cohort
Abstract Number: 0276

Preliminary Analysis of Open-Label Dose-Titration Phase of SLE Treatment with N-Acetylcysteine (SNAC) Shows Evidence for Potential Improvement of SLEDAI, BILAG, ADHD and Fatigue Scores in Patients with Active SLE
Abstract Number: 1522

Preliminary Characterization of Cognitive Dysfunction in Childhood-Onset Systemic Lupus Erythematosus: A CARRA Multi-site Study
Abstract Number: 1236

Preliminary Efficacy and Safety Results of Equecabtagene Autoleucel in Severe Refractory Lupus Nephritis, with a Case of Concomitant Psoriasis and Sjögren’s Syndrome
Abstract Number: 2053

Preliminary Evaluation of 20-Hydroxyecdysone in an In Vitro Osteoarthritis Model: Cellular Responses, Transcriptomic Investigation, and Controlled Delivery Development
Abstract Number: 2541

Preliminary Results of a Patient-Informed, Culturally Tailored Support and Education Pilot Program for Latinx RA Patients
Abstract Number: 0223

Preliminary Safety and Efficacy of a CD19-Targeted In Vivo CAR-T Cell Therapy in Patients with Refractory Systemic Sclerosis
Abstract Number: 1178

Preliminary Safety and Efficacy Results From a First-in-Human Phase 1 Clinical Study of ALLO-329, a Dual Anti-CD19/Anti-CD70 Allogeneic CAR T-Cell Therapy for Autoimmune Disease
Abstract Number: 0903

Preliminary Safety, PK/PD, and Clinical Activity of NKX019, an Allogeneic, CD19-Targeted, CAR NK-Cell Therapy, in Idiopathic Inflammatory Myopathy: Results From an Ongoing, Phase 1/2, Open-Label, Multicenter, Dose-Escalation/Optimization, Basket Study
Abstract Number: 1179

Preliminary Safety, PK/PD, and Clinical Activity of NKX019, an Allogeneic, CD19-Targeted, CAR NK-Cell Therapy, in Systemic Sclerosis: Results From an Ongoing, Phase 1/2, Open-Label, Multicenter, Dose-Escalation/ Optimization, Basket Study
Abstract Number: 0329

Premature Cardiovascular Burden in Young Adults with Systemic Lupus Erythematosus: A Longitudinal Analysis of Selected Cardiovascular Risks Based on Lupus Nephritis Status
Abstract Number: 0462

Prescription Patterns, Safety, and Drug Survival of Targeted Therapies in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease: Data from the BIOBADASER Registry
Abstract Number: 1354

Presence and Impact of Fibromyalgia on Disease Activity, Functioning, and Quality of Life in Spondyloarthritis Patients Along With Validation of Fibromyalgia Rapid Screening Tool (FiRST) Against ACR Fibromyalgia Diagnostic Criteria of 2016
Abstract Number: 2442

Presence of a Phenotype Characterized by Concurrent Onset of Rheumatoid Arthritis and Acute Exacerbation Following Precipitous Relative Lung Volume Decline in Interstitial Lung Disease-Preceding Rheumatoid Arthritis
Abstract Number: 1475

Presence of Human Papilloma Virus and Cervical Dysplasia in Women with SLE
Abstract Number: 1523

Presence of Nailfold Capillary Abnormalities Is Associated with More Severe Organ Involvement in Juvenile Systemic Sclerosis: Results from the Juvenile Systemic Scleroderma Inception Cohort
Abstract Number: 2004

Presentation and Recognition of Apoptotic Cell-Derived Autoantigens Through Efferocytosis
Abstract Number: 2443

Prevalence and Clinical Association of the MUC5B Promoter Variant rs35705950 in Indian Patients With Rheumatoid Arthritis
Abstract Number: 1196

Prevalence and Clinical Associations of Rectal Prolapse in Patients with Systemic Sclerosis
Abstract Number: 0398

Prevalence and Clinical Associations of Sacroiliac Joint MRI Lesions in Patients Referred for Suspected Axial Spondyloarthritis: Real-World Data from the FASTRAX Cohort
Abstract Number: 1567

Prevalence and Clinical Characteristics of Adults with Hypophosphatasia at an Interdisciplinary Osteology Center in a Tertiary Care Hospital
Abstract Number: 0852

Prevalence and Clinical Characteristics of Peripheral Neuropathy in Dermatomyositis: A Retrospective Cohort Study
Abstract Number: 2014

Prevalence and Clinical Characterization of Overweight and Obesity in Psoriatic Arthritis: Data from a Swiss Registry
Abstract Number: 1197

Prevalence and Clinical Correlates of Obstructive and Pre-COPD Phenotypes in Systemic Sclerosis: A CONQUER Investigation
Abstract Number: 1654

Prevalence and Factors Associated with Crowned Dens and Crowned Dens Syndrome in Patients with Calcium Pyrophosphate Arthritis
Abstract Number: 2374

Prevalence and features of neurocognitive impairment in Sjogren’s diseases: French retrospective case series.
Abstract Number: 2545

Prevalence and Impact of Post-Exertional Malaise (PEM) in Fibromyalgia
Abstract Number: 0822

Prevalence and In-Hospital Outcomes of Autoimmune Rheumatic Diseases Among Patients With Hemophagocytic Lymphohistiocytosis: A National Cohort Study
Abstract Number: 1355

Prevalence and Incidence of Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Abstract Number: 1758

Prevalence and Incidence Rate of Patients with Autoimmune-Interstitial Lung Disease in the United States
Abstract Number: 2728

Prevalence and Predictors of Medication Non-Adherence to Mycophenolate Mofetil and Azathioprine in Systemic Autoimmune Rheumatic Diseases
Abstract Number: 0618

Prevalence and Predictors of Pain, Fatigue, and Fibromyalgia in Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
Abstract Number: 0664

Prevalence and risk factors of progressive pulmonary fibrosis in antisynthetase syndrome-associated interstitial lung disease according to the 2022 and 2024 criteria.
Abstract Number: 1391

Prevalence of Cardiovascular Disease in a Population Based Registry of Patients with Sjögren’s Disease
Abstract Number: 1632

Prevalence of Crowned Dens Syndrome among Patients with Polymyalgia Rheumatica
Abstract Number: 2580

Prevalence of Low Back Pain and Its Associated Factors among University Students: A Cross-sectional Study
Abstract Number: 2267

Prevalence of Lupus Nephritis, Advanced Chronic Kidney Disease, Avascular Necrosis, and Mortality in Systemic Lupus Erythematosus in the Contemporary Treatment Era: An Updated Retrospective Cohort Study
Abstract Number: 2341

Prevalence of Malignancy and Associated Factors in Patients with Spondyloarthropathies- A Retrospective Cohort Study
Abstract Number: 1280

Prevalence, Clinical, Genetic Risk Factors, and Time to Cataract Development in Childhood-onset and Adult-onset Systemic Lupus Erythematosus
Abstract Number: 0330

Previous Biologic Exposure Does Not Impact Anifrolumab Effectiveness or Safety: Real World Data from a Nationwide Spanish SLE Cohort
Abstract Number: 2729

Price variation for guideline-directed interstitial lung disease screening and monitoring
Abstract Number: 1542

Prioritizing Research Gaps in Polymyalgia Rheumatica Through a Patient-Informed Modified Delphi Consensus Process
Abstract Number: 0074

PRMT5-dependent dysregulation of nitric oxide metabolism impairs vascular relaxation in inflammatory arthritis
Abstract Number: 2268

Pro-BNP in SLE is Associated with Lower GFR and Prednisone Use (Hydroxychloroquine May Be Protective)
Abstract Number: 0331

Probing Remission in SLE (PRiSE): Abnormal Resting State Functional Connectivity and Regional Brain Metabolism Among individuals With SLE in Clinical Remission
Abstract Number: 1281

Probing Remission in SLE (PRiSE): Health Related Quality of Life in patients with SLE in sustained, drug-free remission
Abstract Number: 1994

Probing Remission in SLE (PRiSE): Persistent Interferon Transcriptional and Epigenetic Signatures Distinguish Serologically Active from Serologically Quiescent Drug-Free Remission
Abstract Number: 0013

Profiling U170-Specific Self-Reactive CD4+ T cells in MCTD and SLE
Abstract Number: 1633

Prognostic Potential of Plasma Protein Biomarkers in Patients with Progressive Pulmonary Fibrosis
Abstract Number: 2507

Prognostic Utility of CD19/CD20 Intrarenal B-Cell Infiltrates in Pediatric Lupus Nephritis
Abstract Number: 1282

Prognostic Value of the 2019 EULAR/ACR Classification Criteria Score in Inception Patients with Renal Domain Involvement
Abstract Number: 2269

Prognostic Value of Time to Kidney Biopsy, Activity Score, and Chronicity Score on Kidney Outcomes in a Cohort of Patients with Newly Diagnosed Membranoproliferative Lupus Nephritis
Abstract Number: 1857

Progression of Systemic Activity, Organ Damage, and Symptom Burden in Sjögren’s Disease: Results from the Prospective Multicenter SjögrenSER-PROS Registry.
Abstract Number: 0746

Progression-Free Survival Among Cancer Patients Treated With Conventional Synthetic DMARDs Versus Biologics for Immune Checkpoint Inhibitor-Induced Immune-Related Adverse Events
Abstract Number: 0718

Progressive Oral Microbiota Dysbiosis and Multi-omics Crosstalk Drive Metabolic and Transcriptional Reprogramming in Gout
Abstract Number: 2270

PROMISing Trajectories: Longitudinal Associations Between Physician-Assessed Disease Activity and Patient-Reported Outcomes in SLE
Abstract Number: 1663

Proof of Concept Evaluation of Large Language Model for Assessment of Gout eConsult Quality Using the eSQUARE Instrument
Abstract Number: 0332

Prospective Risk Stratification for Lupus Nephritis in Systemic Lupus Erythematosus: Retrospective Validation of a Multi-Layer Computational Engine
Abstract Number: 1600

Prospective Validation of DMOMS, A Novel Dermatomyositis-Specific Endpoint, in the Phase 3 VALOR Trial
Abstract Number: 1064

Proteolytic Mapping of the Juvenile Idiopathic Arthritis Synovial Fluid Degradome Identifies Neutrophil Elastase as Potential Driver of Joint Matrix Destruction
Abstract Number: 1934

Proteome-wide autoantibody profiling defines serology-based subtypes of gastrointestinal disease in systemic sclerosis
Abstract Number: 2342

Proteomic analyses in the Phase 2 ARGO trial identify IL 17 signaling-associated markers linked to disease activity, treatment response to sonelokimab, and pharmacodynamic changes in psoriatic arthritis
Abstract Number: 2024

Proteomic Classifier Predicts Clinical and Subclinical Interstitial Lung Disease in Patients with Systemic Autoimmune Rheumatic Diseases
Abstract Number: 1969

Proteomic Profiling Reveals Immune, Metabolic and Tissue Stress Pathways Associated with Articular Disease Burden in Systemic Sclerosis
Abstract Number: 2444

Proteomic signatures associated with incident cardiovascular events in patients with rheumatoid arthritis
Abstract Number: 0525

Protocol Design and Eligibility Criteria as Drivers of Screening Failure in Lupus Clinical Trials: Perspectives from the 2026 LuCIN Annual Survey
Abstract Number: 0224

Proton pump inhibitor use and long-term outcomes in systemic sclerosis: a real-life analysis from the EUSTAR database
Abstract Number: 2652

PRX-115, a Novel PEGylated Uricase: Focus on Plasma levels, Urate Responses and PK-PD Relations Following Single High-Dose Administrations
Abstract Number: 1083

PS-1001, a Novel Pan-Inflammasome Inhibitor Targeting the Adaptor Protein ASC: A Platform Candidate for Inflammasome-Driven Inflammatory Diseases
Abstract Number: 2343

Psoriasis to Psoriatic Arthritis: Interim Phenotypic Analysis from the Preventing Arthritis in a Multicenter Psoriasis At-Risk Study
Abstract Number: 2344

Psoriatic Arthritis Management in the Real-World: Evaluation of Treatment and Provider Patterns Among Patients With Psoriatic Arthritis Using a U.S. EHR Database
Abstract Number: 0014

PsoriAxis Reveals Continuous Molecular Healing and Residual Disease States in Psoriasis
Abstract Number: 0086

Psychedelic 5-HT2A Agonists Reduce Inflammation and Bone Erosion in the hTNF-alpha Mouse Model of Rheumatoid Arthritis
Abstract Number: 2406

Psychopharmacotherapy of Depression Improves Treatment Outcomes in Rheumatoid Arthritis Patients Receiving Anti-IL6 Treatment with Olokizumab and Conventional Disease-modifying Antirheumatic Drugs
Abstract Number: 2532

Psychosocial Factors Associated with Outcomes of Knee Arthroplasty in a Multiethnic Southeast Asian Cohort
Abstract Number: 2445

PTPN22 R620W Risk Allele (rs2476601) in Rheumatoid Arthritis: First Population-Specific Data from an Uzbek Cohort
Abstract Number: 0951

Pulmonary and Cardiovascular Outcomes With Glucagon-Like Peptide-1 Receptor Agonist Use in Obese Patients With Systemic Sclerosis: A Propensity-Matched Cohort Study
Abstract Number: 0242

Pulmonary Arterial Hypertension Identifies a High-Risk Cardiovascular Phenotype and Increased Mortality in Systemic Sclerosis
Abstract Number: 0243

Pulmonary Fibroblast Activation Predicts Lung Function Decline in SSc-ILD: A Longitudinal ⁶⁸Ga-FAPI-PET/CT Study
Abstract Number: 2599

Pulmonary findings in high resolution computed tomography according to the diagnosis and myositis autoantibodies. Results from the MYOTReCSZ cohort
Abstract Number: 2863

Pulmonary Hypertension in Sarcoidosis: In-Hospital Outcomes and Healthcare Disparities in 561,385 US Hospitalizations, 2016-2022
Abstract Number: 2763

Pulmonary Hypertension-Associated Mortality and Disparities in Systemic Sclerosis Among U.S. Adults Aged ≥25 Years, 1999-2024: A CDC WONDER Analysis
Abstract Number: 2446

Pulmonary interventions among Rheumatoid Arthritis Patients Hospitalized with Pneumonia: Pre-COVID versus COVID era
Abstract Number: 1455

Pulmonary Ultrasound Is a Useful Tool for Screening Interstitial Lung Disease Associated to Rheumatoid Arthritis
Abstract Number: 2710

Putting Down Roots in Rural America: A Mixed-Methods Study of Belonging, Isolation, Purpose, and Retention in the Rural Rheumatology Workforce
Abstract Number: 1163

Pyoderma gangrenosum associated with ANCA-associated vasculitis: a French retrospective multicenter study